NASDAQ:SWAVShockwave Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Shockwave Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $44.53 -0.02 (-0.04 %) (As of 06/3/2020 01:28 PM ET) Add Compare Share Today's Range$44.32Now: $44.53▼$45.1050-Day Range$35.09MA: $40.54▼$44.4552-Week Range$22.01Now: $44.53▼$68.39Volume4,760 shsAverage Volume349,030 shsMarket Capitalization$1.42 billionP/E RatioN/ADividend YieldN/ABeta0.82 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More Beat the Market (BTM) Rank™ 2.3 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $42.57, Shockwave Medical has a potential downside of 4.4% from its current price of $44.53.Amount of Analyst CoverageShockwave Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.4 Community Rank Outperform VotesShockwave Medical has received 75 “outperform” votes. (Add your “outperform” vote.)Underperform VotesShockwave Medical has received 84 “underperform” votes. (Add your “underperform” vote.)Community SentimentShockwave Medical has received 52.83% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote “Outperform” if you believe SWAV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $452,320.00 in company stock.Percentage Held by InsidersOnly 15.30% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions78.93% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow in the coming year, from ($2.30) to ($1.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is -23.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is -23.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 6.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.26 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV Previous Symbol CUSIPN/A CIKN/A Webwww.shockwavemedical.com Phone510-279-4262Debt Debt-to-Equity Ratio0.14 Current Ratio10.53 Quick Ratio9.68Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$42.93 million Price / Sales33.05 Cash FlowN/A Price / Cash FlowN/A Book Value$6.81 per share Price / Book6.54Profitability EPS (Most Recent Fiscal Year)($2.14) Net Income$-51,110,000.00 Net Margins-112.25% Return on Equity-38.18% Return on Assets-30.97%Miscellaneous Employees162 Outstanding Shares31,860,000Market Cap$1.42 billion Next Earnings Date8/3/2020 (Estimated) OptionableNot Optionable NASDAQ:SWAV Rates by TradingView Receive SWAV News and Ratings via Email Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter. Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions How has Shockwave Medical's stock been impacted by COVID-19 (Coronavirus)? Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SWAV shares have increased by 29.3% and is now trading at $44.53. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Shockwave Medical? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical. When is Shockwave Medical's next earnings date? Shockwave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Shockwave Medical. How were Shockwave Medical's earnings last quarter? Shockwave Medical Inc (NASDAQ:SWAV) posted its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.49) by $0.10. The company had revenue of $15.20 million for the quarter, compared to analysts' expectations of $14.17 million. Shockwave Medical had a negative return on equity of 38.18% and a negative net margin of 112.25%. Shockwave Medical's quarterly revenue was up 109.1% on a year-over-year basis. During the same quarter in the previous year, the business posted ($1.37) earnings per share. View Shockwave Medical's earnings history. What price target have analysts set for SWAV? 7 brokerages have issued 12 month price targets for Shockwave Medical's stock. Their forecasts range from $23.00 to $50.00. On average, they expect Shockwave Medical's stock price to reach $42.57 in the next year. This suggests that the stock has a possible downside of 4.4%. View analysts' price targets for Shockwave Medical. Has Shockwave Medical been receiving favorable news coverage? News headlines about SWAV stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Shockwave Medical earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the next several days. View the latest news aboutShockwave Medical. Are investors shorting Shockwave Medical? Shockwave Medical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,970,000 shares, an increase of 12.5% from the April 15th total of 3,530,000 shares. Based on an average daily volume of 496,600 shares, the short-interest ratio is presently 8.0 days. Currently, 16.3% of the company's shares are sold short. View Shockwave Medical's Current Options Chain. Who are some of Shockwave Medical's key competitors? Some companies that are related to Shockwave Medical include Haemonetics (HAE), Globus Medical (GMED), Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inovio Pharmaceuticals (INO), Inspire Medical Systems (INSP), AtriCure (ATRC), Cantel Medical (CMD), Glaukos (GKOS) and Luminex (LMNX). View all competitors. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), salesforce.com (CRM), Alibaba Group (BABA), Walt Disney (DIS), Trade Desk (TTD), Roku (ROKU), Paypal (PYPL), Square (SQ), Twilio (TWLO) and Shopify (SHOP). Who are Shockwave Medical's key executives? Shockwave Medical's management team includes the following people: Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)Mr. Daniel Puckett, CFO & Sec. (Age 55)Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72) When did Shockwave Medical IPO? (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is Shockwave Medical's stock symbol? Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV." Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wellington Management Group LLP (6.29%), BlackRock Inc. (4.76%), JPMorgan Chase & Co. (4.44%), Alpine Global Management LLC (4.17%), Wells Fargo & Company MN (3.59%) and Jennison Associates LLC (1.81%). Company insiders that own Shockwave Medical stock include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias, James E Flynn and Sofinnova Capital Vii Fcpr. View institutional ownership trends for Shockwave Medical. Which major investors are selling Shockwave Medical stock? SWAV stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Balyasny Asset Management LLC, UBS Group AG, Morgan Stanley, Morgan Stanley, Redmile Group LLC, Jennison Associates LLC, and Legal & General Group Plc. Company insiders that have sold Shockwave Medical company stock in the last year include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias, and Sofinnova Capital Vii Fcpr. View insider buying and selling activity for Shockwave Medical. Which major investors are buying Shockwave Medical stock? SWAV stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Wellington Management Group LLP, Alpine Global Management LLC, JPMorgan Chase & Co., AXA, BlackRock Inc., Aviva PLC, and Copernicus Capital Management LLC. View insider buying and selling activity for Shockwave Medical. How do I buy shares of Shockwave Medical? Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Shockwave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $44.53. How big of a company is Shockwave Medical? Shockwave Medical has a market capitalization of $1.42 billion and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe. What is Shockwave Medical's official website? The official website for Shockwave Medical is www.shockwavemedical.com. How can I contact Shockwave Medical? Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected] This page was last updated on 6/3/2020 by MarketBeat.com Staff
